搜期刊
刊名

文献信息

  • 任意字段
  • 主题词
  • 篇关摘
  • 篇名
  • 关键词
  • 摘要
  • 作者
  • 第一作者
  • 作者单位
  • 刊名
  • 中图分类号
  • 学科分类号
  • DOI
  • 基金

Cancer Pathogenesis and Therapy 中科院4区 JCR:Q2 ESCI PubMed
发文量 251
被引量 852

Cancer Pathogenesis and Therapy (CPT) is an international open access journal covering key topics in all aspects of cancer research, focusing on mechanism innovation, emerging interdisciplinary and clinical trials research in Oncology. As a Chinese Medical Association (CMA) journal, it strives to publish the highest quality content that provides authoritative guidance to oncology specialists, physicians and researchers. CPT is dedicated to publishing innovative and significant research results in basic research, translation research and clinical oncology, including novel antitumor drugs, especially clinical trials, early screening/prevention, precise diagnosis and targeted therapy, interdisciplinary oncology innovation research and clinical translation in genetics, bioinformatics, pharmacology, and biology, and also new viewpoints, new ideas, new methods and new models of cancer prevention and public health policy.

  • 主管单位: 中国科协
  • 主办单位: 中华医学会
  • 出版地区: 北京市
  • 出版周期: 双月刊
  • 别名: 癌症发生与治疗(英文);CANCER PATHOGENESIS AND THERAPY
  • 国内统一连续出版物号: CN 10-1882/R
  • 国际标准连续出版物号/电子版 ISSN 2097-2563 / EISSN 2949-7132
  • 创刊时间: 2023年
收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
新发布(2025版)
分析评价

期刊信息

  • 主管单位:中国科协
  • 主办单位:中华医学会
  • 主  编:石远凯;David James Kerr
  • 地  址: 北京市
  • 邮政编码:100052
  • 电子邮件: cpt@cmaph.org
  • 单  价:80.00
  • 电  话:
    010-51322177

期刊简介

Cancer Pathogenesis and Therapy (CPT) is an international open access journal covering key topics in all aspects of cancer research, focusing on mechanism innovation, emerging interdisciplinary and clinical trials research in Oncology. As a Chinese Medical Association (CMA) journal, it strives to publish the highest quality content that provides authoritative guidance to oncology specialists, physicians and researchers. CPT is dedicated to publishing innovative and significant research results in basic research, translation research and clinical oncology, including novel antitumor drugs, especially clinical trials, early screening/prevention, precise diagnosis and targeted therapy, interdisciplinary oncology innovation research and clinical translation in genetics, bioinformatics, pharmacology, and biology, and also new viewpoints, new ideas, new methods and new models of cancer prevention and public health policy.

获奖情况

  • 卓越计划期刊